Back | Next |
home / stock / ctlt / ctlt message board
Subject | By | Source | When |
---|---|---|---|
Have a look at this | Trend-Setter | investorshub | 04/12/2023 6:21:51 PM |
news out | Phosphene | investorshub | 04/12/2023 3:22:20 PM |
$CTLT great news | Trueheart | investorshub | 04/12/2023 12:05:46 AM |
$CTLT are we finally gonna see some action | Trend-Setter | investorshub | 04/11/2023 11:07:59 PM |
$CTLT are we finally gonna see some action | Phosphene | investorshub | 04/11/2023 4:00:49 PM |
$CTLT Do we have a winner?Turn around time? | Phosphene | investorshub | 04/11/2023 2:10:34 AM |
$CTLT Do we have a winner?Turn around time? | Trend-Setter | investorshub | 04/09/2023 10:24:07 AM |
Catalent Launches CosmoPod Duo - New Dual Chamber | Phosphene | investorshub | 02/10/2021 2:31:16 AM |
Catalent and Decibel Team Up to Develop Gene | Phosphene | investorshub | 02/10/2021 2:30:25 AM |
Catalent Signs Development and Manufacturing Agreement with Trizell | Phosphene | investorshub | 02/08/2021 5:16:54 PM |
$CDMO Catalent trumpets biologics windfall courtesy of COVID-19 | Phosphene | investorshub | 02/03/2021 9:13:52 PM |
Catalent has their checkbook out. | Phosphene | investorshub | 01/27/2021 12:36:30 AM |
Catalent, zydis,mymx | steel8000 | investorshub | 01/12/2021 1:06:44 PM |
Novan Engages Catalent to Develop Intranasal Formulation of | Phosphene | investorshub | 12/22/2020 5:25:49 PM |
Catalent Appoints Minakuchi Facility GM | Phosphene | investorshub | 12/10/2020 3:48:25 PM |
Passage Bio Teams with Catalent to Start CGMP | Phosphene | investorshub | 12/08/2020 6:05:05 PM |
Catalent to Invest $10 Million to Expand High | Phosphene | investorshub | 12/04/2020 1:21:07 AM |
Thanks for the info, Phosphene. | Trueheart | investorshub | 11/30/2020 5:14:58 AM |
Hello Trueheart. | Phosphene | investorshub | 11/29/2020 11:20:35 PM |
Catalent Signs Commercial Supply Agreement with Blueprint Medicines | Phosphene | investorshub | 11/29/2020 11:14:10 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Catalent, Inc. (NYSE: CTLT) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.37% on the day to $56.66. Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologi...